Tcw Group Inc Alnylam Pharmaceuticals, Inc. Transaction History

Tcw Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$122.97 - $147.0 $4.06 Million - $4.85 Million	-33,005 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$121.19 - $165.49 $731,745 - $999,228	-6,038 Reduced 15.47%	33,005 $4.81 Million
Q2 2020 Aug 05, 2020	SELL	$104.21 - $156.44 $38,140 - $57,257	-366 Reduced 0.93%	39,043 $5.78 Million
Q1 2020 May 05, 2020	BUY	$93.12 - $133.99 $3.67 Million - $5.28 Million	39,409 New	39,409 $4.29 Million

654

111M

2.14M

1.91M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.